NIH restarts manufacturing of rabies vaccine
The locally manufactured anti-rabies vaccine is expected to be available at public-sector health services
The locally manufactured anti-rabies vaccine is expected to be available at public-sector health services. PHOTO: FILE
ISLAMABAD:
The National Institute of Health (NIH) has restarted the production of Cell Culture Rabies Vaccine (CCRV). The vaccine is currently undergoing quality control analysis.
The locally manufactured anti-rabies vaccine is expected to be available at public-sector health services department by February.
NIH Executive Director Professor Brigadier Aamer Ikram stated that the NIH is currently producing CCRV and the anti-Rabies serum. Both products are supplied on demand to all provinces, Azad Jammu and Kashmir, the armed forces and others, he added.
After seven years: NIH restarts production of measles vaccine
He added that the NIH also provides a diagnostic facility for Rabies Antibodies Titre (RAT) after the vaccination process.
The institute has assured the Ministry of National Health Services Regulation and Coordination that it will utilise all available resources to meet the country's need for rabies vaccines and anti-sera production.
Published in The Express Tribune, January 3rd, 2019.
The National Institute of Health (NIH) has restarted the production of Cell Culture Rabies Vaccine (CCRV). The vaccine is currently undergoing quality control analysis.
The locally manufactured anti-rabies vaccine is expected to be available at public-sector health services department by February.
NIH Executive Director Professor Brigadier Aamer Ikram stated that the NIH is currently producing CCRV and the anti-Rabies serum. Both products are supplied on demand to all provinces, Azad Jammu and Kashmir, the armed forces and others, he added.
After seven years: NIH restarts production of measles vaccine
He added that the NIH also provides a diagnostic facility for Rabies Antibodies Titre (RAT) after the vaccination process.
The institute has assured the Ministry of National Health Services Regulation and Coordination that it will utilise all available resources to meet the country's need for rabies vaccines and anti-sera production.
Published in The Express Tribune, January 3rd, 2019.